Psilocybin for OCD

(Mushroom-OCD Trial)

This trial tests psilocybin, a compound found in certain mushrooms, to determine its effectiveness in helping people with obsessive-compulsive disorder (OCD) manage their symptoms. Participants will receive one of three randomly assigned doses of psilocybin chocolate to assess its impact on OCD. Ideal candidates have moderate to severe OCD, have not found success with other treatments, and are not currently using mind-altering drugs. As a Phase 1 trial, this research aims to understand how psilocybin works in people, offering participants the opportunity to be among the first to receive this innovative treatment.

Yes, you will need to stop taking certain medications and supplements at least two weeks before starting the trial. This includes antidepressants, antipsychotics, and serotonin-acting supplements. If you're taking fluoxetine, it must be stopped at least six weeks prior.

Research has shown that psilocybin, found in certain mushrooms, is generally safe when used in a controlled environment. One study found that doses up to 10 mg were well-tolerated by people with OCD, with no serious side effects. Another study demonstrated that multiple doses could be safely administered in a research setting. Psilocybin has also been used safely in other trials, showing potential benefits for people with OCD. Although this trial is just starting, these findings suggest that psilocybin is well-tolerated by most people when given under supervision.¹²³⁴⁵

Most treatments for OCD, like SSRIs and cognitive behavioral therapy, focus on managing symptoms over time. But the psilocybin whole mushroom treatment is different. It's derived from a naturally occurring psychedelic compound found in mushrooms, which is thought to work by disrupting negative thought patterns and potentially rewiring brain connectivity. Researchers are excited because psilocybin has shown promise in producing rapid and lasting effects, possibly offering relief in just a single or few doses compared to the weeks or months required for traditional treatments. Plus, it’s administered in a novel chocolate matrix, which could make the experience more palatable and pleasant for patients.

Research has shown that psilocybin, a substance found in certain mushrooms, may help treat obsessive-compulsive disorder (OCD). In one study, psilocybin greatly reduced OCD symptoms, with about 30% of participants noticing improvements. Another study discovered that just one dose of psilocybin quickly reduced compulsive symptoms, with effects lasting up to a week. Additionally, taking psilocybin multiple times during the first month of treatment provided significant relief from symptoms. These findings suggest that psilocybin could effectively manage OCD symptoms. In this trial, participants will receive different doses of psilocybin to evaluate its effectiveness and safety in treating OCD.¹⁴⁶⁷⁸